Itonic Holdings Ltd. (NASDAQ:ITOC – Get Free Report) was the recipient of a significant decline in short interest in the month of October. As of October 30th, there was short interest totaling 4,034 shares, a decline of 59.8% from the October 15th total of 10,047 shares. Based on an average daily volume of 19,180 shares, the days-to-cover ratio is presently 0.2 days. Approximately 0.1% of the shares of the company are sold short.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings lowered shares of Itonic from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, September 24th. One analyst has rated the stock with a Sell rating. According to data from MarketBeat, Itonic has a consensus rating of “Sell”.
View Our Latest Stock Analysis on Itonic
Itonic Trading Down 4.8%
ITOC stock traded down $0.10 during mid-day trading on Monday, hitting $1.89. 47,646 shares of the company were exchanged, compared to its average volume of 29,414. Itonic has a 1-year low of $1.63 and a 1-year high of $18.40. The business has a 50 day simple moving average of $3.64 and a 200-day simple moving average of $4.74.
Itonic (NASDAQ:ITOC – Get Free Report) last released its quarterly earnings results on Wednesday, September 30th. The company reported ($0.75) earnings per share (EPS) for the quarter. The company had revenue of $0.05 million during the quarter.
Itonic Company Profile
iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients.
Further Reading
- Five stocks we like better than Itonic
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Itonic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itonic and related companies with MarketBeat.com's FREE daily email newsletter.
